Latest filing published 05 Dec 2006 for SAVIENT PHARMACEUTICALS INC.
Insider track record
No signal scores available.
David Tendler: trading record in brief
All filings by David Tendler on record concern Savient Pharmaceuticals Inc. Over a trading history stretching from 30 December 2005 to 30 March 2007, the count stands at 10 filings.
The open-market record consists of 1 sale worth €7,882, with no purchase. Other entries cover 7 share grants.
Most recently, on 3 April 2007, the filings show a share grant worth €2,798 in Savient Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Tendler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 900 shares0Common Stock, $.01 par value per shareSEC:0001230295-06-000301:0
- 900 shares0Common Stock, $.01 par value per shareSEC:0001230295-06-000301:1
- 900 shares@ US$11.68Common Stock, $.01 par value per shareSEC:0001230295-06-000301:2
- 703 shares@ US$5.33Common Stock, $.01 par value per shareSEC:0001230295-06-000089:0
4 of 4 declarations
